Prognostic Tests of Intolerance to Postpyloric Feeding in Early Acute Pancreatitis

Aim. To evaluate the effectiveness of postpyloric feeding in early predicted severe acute pancreatitis using acetaminophen absorption test and gastric emptying rate.

Material and methods. An open observational prospective cohort study in the intensive care unit of OAO «Neftyanik» hospital in the city of Tyumen, Russia, from November 2012 to October 2018 was performed. All included patients were diagnosed with predicted severe acute pancreatitis (inclusion criterion). The rate of gastric emptying was assessed using an original ultrasound technique which involved measuring the fluid volume 30 min and 60 min after administering of 200 mL aliquote of water into the stomach. Acetaminophen absorption test was performed according to the following procedure: 0.5 g of acetaminophen was administered through the nasojunal tube placed 30–40 cm distal to the Treitz ligament using endoscope, the blood level of the drug was measured 5–20 min later.

Results. Gastric fluid volume at 60 min (OR=1.049, 95% CI: 1.028–1.07, P<0.001 with AUC=0.921, 95% CI: 0.808–0.944 and cutoff value of 73.5) was a significant predictor of residual gastric volume ≥ 500 mL/d and intolerance to enteral feeding through the nasojejunal tube (OR=1.023, 95% CI: 1.009–1.036, P=0.001 with AUC 0.752, 95% CI: 0.629–0.875, with cutoff value of 79.5). The acetaminophen small intestine absorption test was reliable in predicting the residual gastric volume ≥ 500 mL/d for the early period of disease. The acetaminophen absorption test was a significant predictor of intolerance to enteral feeding through the nasojejunal tube only in patients with severe acute pancreatitis (OR=0.834, 95% CI: 0.733–0.949, P<0.001 with AUC=0.894, 95% CI: 0.770–0.1 with cutoff value of 14.6).

Conclusion. Throughout the early period of acute pancreatitis, gastric fluid volume measured 60 min after the administration of 200 mL of water, accurately predicts the residual gastric volume I 500 mL/day. Acetaminophen absorption test in the small intestine can reliably predict intolerance to postpyloric feeding only for patients with severe acute pancreatitis.

1. Blaser A.R., Malbrain M.L.N.G., Starkopf J., Fruhwald S., Jakob S., De Waele J., Braun J.P., Poeze M., Spies C. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med. 2012; 38 (3): 384–394. DOI: 10.1007/s00134-011-2459-y. PMID: 22310869.

2. Banks P.A., Bollen T.L., Dervenis C., Gooszen H.G., Johnson C.D., Sarr M.G., Tsiotos G.G., Vege S.S., Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013; 62 (1): 102–111. DOI: 10.1136/gutjnl-2012-302779. PMID: 23100216.

3. Сивков О.Г., Сивков А.О., Попов И.Б., Зайцев Е.Ю. Тяжесть заболевания как фактор риска непереносимости энтерального питания в ранний период острого панкреатита. Уральский медицинский журнал. 2021; 20 (4): 53–59. DOI: 10.52420/2071-5943-2021-20-4-53-59.

4. Сивков О.Г., Пономарева М.А., Попов И.Б. Эпидемиология и качественные показатели лечения больных с предикторами тяжелого течения острого некротизирующего панкреатита в МСЧ «Нефтяник» за 2008–2012 гг. Медицинская наука и образование Урала. 2014; 15 (2): 133–135 (In Russ.)] eLIBRARY ID: 22580641.

5. Kar P., Jones K.L., Horowitz M., Chapman M.J., Deane A.M. Measurement of gastric emptying in the critically ill. Clin Nutr. 2015; 34 (4): 557–564. DOI: 10.1016/j.clnu.2014.11.003. PMID: 25491245.

6. Medhus A.W., Lofthus C.M., Bredesen J., Husebye E. Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics. Neurogastroenterol Motil. 2001; 13 (3): 179–185. DOI: 10.1046/j.1365-2982.2001.00249.x. PMID: 11437980.

7. Сивков О.Г., Лейдерман И.Н., Луцюк М.И. Прогнозирование непереносимости энтерального питания у пациентов в критическом состоянии. Вестник интенсивной терапии им. А.И. Салтанова. 2020; 4: 120–126. DOI: 10.21320/1818-474X-2020-4-120-126.

8. Miyauchi T., Ishikawa M., Tashiro S., Hisaeda H., Nagasawa H., Himeno K. Acetaminophen absorption test as a marker of small bowel transplant rejection. Transplantation. 1997; 63 (8): 1179–1182. DOI: 10.1097/00007890-199704270-00020. PMID: 9133482.

9. Tenner S., Baillie J., DeWitt J., Vege S.S., American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013; 108 (9): 1400–1415; 1416. DOI: 10.1038/ajg.2013.218. PMID: 23896955.

10. Сивков О.Г. Прогнозирование возможности питания в тонкую кишку у пациентов с распространенным вторичным перитонитом. Общая реаниматология. 2021; 17 (1): 27–33. DOI: 10.15360/1813-9779-2021-1-27-33.

11. Capurso G., Zerboni G., Signoretti M., Valente R., Stigliano S., Piciucchi M., Delle Fave G. Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol. 2012; 46 Suppl: S46-51. DOI: 10.1097/MCG.0b013e3182652096. PMID: 22955357.

12. Ge P., Luo Y., Okoye C.S., Chen H., Liu J., Zhang G., Xu C., Chen H. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: a troublesome trio for acute pancreatitis. Biomed Pharmacother. 2020; 132: 110770. DOI: 10.1016/j.biopha.2020.110770. PMID: 33011613.

13. Blander J.M. On cell death in the intestinal epithelium and its impact on gut homeostasis Curr. Opin. Gastroenterol. 2018; 34 (6): 413–419. DOI: 10.1097/MOG.0000000000000481. PMID: 30169459.

14. Tian R., Tan J-T., Wang R-L., Xie H., Qian Y-B., Yu K-L. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis Eur Rev Med Pharmacol Sci. 2013; 17 (3): 349–355. PMID: 23426538.

15. Arike L., Hansson G.C. The densely O-Glycosylated MUC2 mucin protects the intestine and provides food for the commensal bacteria. J Mol Biol. 2016; 428 (16): 3221–3229. DOI: 10.1016/j.jmb.2016.02.010. PMID: 26880333.

16. Bakshani C.R., Morales-Garcia A.L., Althaus M., Wilcox M.D., Pearson J.P., Bythell J.C., Burgess J.G. Evolutionary conservation of the antimicrobial function of mucus: a first defense against infection. NPJ Biofilms Microbiomes. 2018; 4: 14. DOI: 10.1038/s41522-018-0057-2. PMID: 30002868.

17. Fishman J.E., Levy G., Alli V., Zheng X., Mole D.J., Deitch E.A. The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis. Shock. 2014; 42 (3): 264–270. DOI: 10.1097/SHK.0000000000000209. PMID: 24978882.

18. Li X-Y., He C., Zhu Y., Lu N-H. Role of gut microbiota on intestinal barrier function in acute pancreatitis. World J Gastroenterol. 2020; 26 (18): 2187–2193. DOI: 10.3748/wjg.v26.i18.2187. PMID: 32476785.

19. Hynönen U., Palva A. Lactobacillus surface layer proteins: structure, function and applications Appl. Microbiol. Biotechnol. 2013; 97 (12): 5225–5243. DOI: 10.1007/s00253-013-4962-2. PMID: 23677442.

20. Hsieh C-Y., Osaka T., Moriyama E., Date Y., Kikuchi J., Tsuneda S. Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum. Physiol Rep. 2015; 3 (3): e12327. DOI: 10.14814/phy2.12327. PMID: 25780093.

21. Kelly C.J., Zheng L., Campbell E.L., Saeedi B., Scholz C.C., Bayless A.J., Wilson K.E., Glover L.E., Kominsky D.J., Magnuson A., Weir T.L., Ehrentraut S.F., Pickel C., Kuhn K.A., Lanis J.M., Nguyen V., Taylor C.T., Colgan S.P. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015; 17 (5): 662–671. DOI: 10.1016/j.chom.2015.03.005. PMID: 25865369.

22. Tan C., Ling Z., Huang Y., Cao Y., Liu Q., Cai T., Yuan H., Liu C., Li Y., Xu K. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis. Pancreas. 2015; 44 (6): 868–875. DOI: 10.1097/MPA.0000000000000355. PMID: 25931253.

23. Zhu Y., He C., Li X., Cai Y., Hu J., Liao Y., Zhao J., Xia L., He W., Liu L., Luo C., Shu X., Cai Q., Chen Y., Lu N. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice. J Gastroenterol. 2019; 54 (4): 347–358. DOI: 10.1007/s00535-018-1529-0. PMID: 30519748.

24. Leal-Lopes C., Velloso F.J., Campopiano J.C., Sogayar M.C., Correa R.G. Roles of commensal microbiota in pancreas homeostasis and pancreatic pathologies J Diabetes Res. 2015; 2015: 284680. DOI: 10.1155/2015/284680. PMID: 26347203.

25. Besselink M.G., van Santvoort H.C., Boermeester M.A., Nieuwenhuijs V.B., van Goor H., Dejong C.H., Schaapherder A.F., Gooszen H.G., Dutch Acute Pancreatitis Study Group. Timing and impact of infections in acute pancreatitis. Br J Surg. 2009; 96 (3): 267–273. DOI: 10.1002/bjs.6447. PMID: 19125434.

26. Guo Q., Li A., Xia Q., Liu X., Tian B., Mai G., Huang Z., Chen G., Tang W., Jin X., Chen W., Lu H., Ke N., Zhang Z., Hu W. The role of organ failure and infection in necrotizing pancreatitis: a prospective study. Ann Surg. 2014; 259 (6): 1201–1207. DOI: 10.1097/SLA.0000000000000264. PMID: 24169172.

27. Werge M., Novovic S., Schmidt P.N., Gluud L.L. Infection increases mortality in necrotizing pancreatitis: a systematic review and meta-analysis. Pancreatology. 2016; 16 (5): 698–707. DOI: 10.1016/j.pan.2016.07.004. PMID: 27449605.

28. Sakamoto W., Masuno T., Yokota H., Takizawa T. Expression profiles and circulation dynamics of rat mesenteric lymph microRNAs. Mol Med Rep. 2017; 15 (4): 1989–1996. DOI: 10.3892/mmr.2017.6259. PMID: 28259929.

29. Aydin S., Isik A.T., Unal B., Comert B., Ozyurt M., Deveci S., Ozgur G., Cengiz O., Tasci I., Mas M.R. Effects of infliximab on bacterial translocation in experimental acute necrotizing pancreatitis. Indian J Med Res. 2012; 135 (5): 656–661. PMID: 22771595.

30. Fritz S., Hackert T., Hartwig W., Rossmanith F., Strobel O., Schneider L., Will-Schweiger K., Kommerell M., Büchler M.W., Werner J. Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg. 2010; 200 (1): 111–117. DOI: 10.1016/j.amjsurg.2009.08.019. PMID: 20637344.

31. Al-Omran M., Albalawi Z.H., Tashkandi M.F., Al-Ansary L.A. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev. 2010; 2010 (1): CD002837. DOI: 10.1002/14651858.CD002837.pub2. PMID: 20091534.

32. Petrov M.S., van Santvoort H.C., Besselink M.G., van der Heijden G.J., Windsor J.A., Gooszen H.G. Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg. 2008; 143 (11): 1111–1117. DOI: 10.1001/archsurg.143.11.1111. PMID: 19015471.

33. Dellinger E.P., Forsmark C.E., Layer P., Lévy P., Maraví-Poma E., Petrov M.S., Shimosegawa T., Siriwardena A.K., Uomo G., Whitcomb D.C., Windsor J.A., Pancreatitis Across Nations Clinical Research and Education Alliance (PANCREA). Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg. 2012; 256 (6): 875–880. DOI: 10.1097/SLA.0b013e318256f778. PMID: 22735715.

34. Murphy A.E., Codner P.A. Acute pancreatitis: exploring nutrition implications. Nutr Clin Pract. 2020; 35 (5): 807–817. DOI: 10.1002/ ncp.10479. PMID: 32181949.

35. van Dijk S.M., Hallensleben N.D.L., van Santvoort H.C., Fockens P., van Goor H., Bruno M.J., Besselink M.G., Dutch Pancreatitis Study Group. Acute pancreatitis: recent advances through randomized trials. Gut. 2017; 66 (11): 2024–2032. DOI: 10.1136/gutjnl-2016-313595. PMID: 28838972.

36. Hegazi R.A., DeWitt T. Enteral nutrition and immune modulation of acute pancreatitis. World J Gastroenterol. 2014; 20 (43): 16101–16105. DOI: 10.3748/wjg.v20.i43.16101. PMID: 25473161.

37. Klek S., Sierzega M., Turczynowski L., Szybinski P., Szczepanek K., Kulig J. Enteral and parenteral nutrition in the conservative treatment of pancreatic fistula: a randomized clinical trial. Gastroenterology. 2011; 141 (1): 157–163. DOI: 10.1053/j.gastro.2011.03.040. PMID: 21439962.

38. Chang Y-S., Fu H-Q., Xiao Y-M. Liu J-C. Nasogastric or nasojejunal feeding in predicted severe acute pancreatitis: a meta-analysis. Crit Care. 2013; 17 (3): R118. DOI: 10.1186/cc12790. PMID: 23786708.

39. Singh N., Sharma B., Sharma M., Sachdev V., Bhardwaj P., Mani K., Joshi Y.K., Saraya A. Evaluation of early enteral feeding through nasogastric and nasojejunal tube in severe acute pancreatitis: a noninferiority randomized controlled trial. Pancreas. 2012; 41 (1): 153–159. DOI: 10.1097/MPA.0b013e318221c4a8. PMID: 21775915.

40. Eatock F.C., Chong P., Menezes N., Murray L., McKay C.J., Carter C.R., Imrie C.W. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol. 2005; 100 (2): 432–439. DOI: 10.1111/j.1572-0241.2005.40587.x. PMID: 15667504.

41. Dutta A.K., Goel A., Kirubakaran R., Chacko A., Tharyan P. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis. Cochrane Database Syst Rev. 2020; 3 (3): CD010582. DOI: 10.1002/14651858.CD010582.pub2. PMID: 32216139.

42. Singer P., Blaser A.R., Berger M.M., Alhazzani W., Calder P.C., Casaer M.P., Hiesmayr M., Mayer K., Montejo J.C., Pichard C., Preiser J.C., van Zanten A.R.H., Oczkowski S., Szczeklik W., Bischoff S.C. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019; 38 (1): 48–79. DOI: 10.1016/j.clnu.2018.08.037. PMID: 30348463.

43. Reintam A., Parm P., Kitus R., Kern H., Starkopf J. Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand. 2009; 53 (3): 318–324. DOI: 10.1111/j.1399-6576.2008.01860.x. PMID: 19243317.

44. Kreymann K.G., Berger M.M., Deutz N.E.P., Hiesmayr M., Jolliet P., Kazandjiev G., Nitenberg G., van den Berghe G., Wernerman J., Ebner C., Hartl W., Heymann C., Spies C. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr. 2006; 25 (2): 210–223. DOI: 10.1016/j.clnu.2006.01.021. PMID: 16697087.

45. Wang W-N., Yang M-F., Wang C-Y., Hsu C-Y., Lee B-J., Fu P-K. Optimal time and target for evaluating energy delivery after adjuvant feeding with small bowel enteral nutrition in critically ill patients at high nutrition risk. Nutrients. 2019; 11 (3): 645. DOI: 10.3390/nu11030645. PMID: 30884840.